Document is current
Any future updates will be listed below
-
Authors
Hogarth, Marshall W.
Houweling, Peter J.
Thomas, Kristen C.
Gordish-Dressman, Heather
Bello, Luca
,
Vishwanathan, V.
Chidambaranathan, S.
Douglas Biggar, W.
McAdam, Laura C.
Mah, Jean K.
Tulinius, Mar
Cnaan, Avital
Morgenroth, Lauren P.
Leshner, Robert
Tesi-Rocha, Carolina
Thangarajh, Mathula
Duong, Tina
Kornberg, Andrew
Ryan, Monique
Nevo, Yoram
Dubrovsky, Alberto
Clemens, Paula R.
Abdel-Hamid, Hoda
Connolly, Anne M.
Pestronk, Alan
Teasley, Jean
Bertorini, Tulio E.
Webster, Richard
Kolski, Hanna
Kuntz, Nancy
Driscoll, Sherilyn
Bodensteiner, John B.
Carlo, Jose
Gorni, Ksenija
Lotze, Timothy
Day, John W.
Karachunski, Peter
Henricson, Erik K.
Abresch, Richard T.
McDonald, Craig M.
Pegoraro, Elena
Hoffman, Eric P.
Head, Stewart I.
North, Kathryn N.
- License Information
-
More Information
Article History
Received: 11 December 2015
Accepted: 22 November 2016
First Online: 31 January 2017
Competing interests
: E.P.H. has served on advisory committees for AVI BioPharma, Inc., as a consultant with the Gerson Lehman Group, Medacorp, and Lazard Capital, and is cofounder, board member, and shareholder of ReveraGen Biopharma. The remaining authors declare no competing financial interests.
